Top 30 Next-Generation Sequencing Interview Questions and Answers [Updated 2025]

During my master's thesis, I collaborated with biologists and bioinformaticians on a project sequencing plant genomes. My role was to analyze the sequencing data using statistical software. I set up regular meetings and used shared documents to update everyone on progress, which helped ensure that we all stayed aligned throughout the project.

In my previous role, I led a team to implement a novel NGS workflow. My goal was to reduce turnaround time for sample processing. I ensured clear communication and held weekly check-ins to address any issues. This approach kept the team motivated and aligned. We succeeded in reducing processing time by 30%, enhancing throughput.

At my previous job, I introduced a cloud-based data management system for NGS data analysis. We were facing issues with data storage and retrieval which slowed our workflows. I proposed the system after researching several options and led the implementation team. As a result, we reduced data retrieval times by 50%, significantly speeding up our analysis process.

I prioritize my NGS projects by assessing their deadlines and overall impact on the lab's goals. For example, I focus on the high-impact projects first and use tools like Trello to track tasks and deadlines.

In my previous role, we had a sudden shift from short-read to long-read sequencing technology. Initially, I was concerned about our timeline, but I quickly organized a team meeting to assess our capabilities. We divided tasks to learn the new technology and adjusted our project milestones. As a result, we successfully completed the project within the new timeline and expanded our sequencing abilities.

I keep my skills up-to-date by regularly reading research articles from journals like Nature and PLOS Genetics. I also participate in webinars and online courses that focus on the latest NGS techniques.

In a recent NGS project, I faced a challenge with low-quality sequence reads. I used trimming tools like Trimmomatic to improve the data quality before alignment. I validated the trimmed data by checking the quality scores, and the analysis led to an increase in mapped reads, which enhanced our genetic variant detection.

In a previous project, a colleague and I disagreed on whether to use a denoising algorithm for our RNA-Seq data. I believed it would enhance the quality, while they thought it would oversimplify the data. I proposed we validate both approaches with a subset of data. After analyzing the results together, we concluded that the denoising algorithm provided clearer insights. This experience taught us the value of data-driven discussions and deepened our collaboration skills.

In a recent NGS project focused on whole genome sequencing, I identified sequencing errors by analyzing quality control metrics. By adjusting the parameters for base calling, we improved the base accuracy from 95% to 98%, significantly enhancing our variant calling reliability.

I would first evaluate the projects based on their potential to contribute significant findings to our understanding of genomics. Then, I would align the projects with our organization's goals to ensure they are impactful. Next, I would assess which projects are feasible based on our limited resources. If there are opportunities for collaboration, that could also influence my decision, as it would enhance our capacity.

I would compare the sequencing results to a book, explaining how each gene is like a chapter that tells a part of the story about an individual's health. This way, I can help the client understand the overall message without getting lost in the technicalities.

First, I would review the sample preparation protocols to identify any steps where contamination could have occurred. Then, I would check the integrity of reagents and consumables used in the sequencing process. After that, I'd reanalyze the raw data for quality metrics to isolate the problem.

I would first identify the stakeholders, such as patients, families, and healthcare providers. I'd assess how the sequencing results impact each group and prepare targeted communications to address their specific ethical concerns. I'd ensure transparency in the findings and outline potential actions based on the results, while remaining open to questions and feedback.

First, I would examine the quality scores of the sequencing data to identify any significant drops in quality. Then, I would compare the results to a control sample to see if the error is consistent. If I find discrepancies, I would utilize visualization tools to inspect alignment files for patterns that indicate systematic bias.

I would start by categorizing each project based on deadlines and critical milestones. Then, I would communicate with my team to assess their current workloads and any bottlenecks they're facing. Using this information, I would prioritize the projects that are most urgent while ensuring that we remain on track with our long-term goals.

First, I would check the quality of the input DNA using a spectrophotometer and a bioanalyzer. Next, I would review the library prep protocol to ensure all steps were followed correctly. Additionally, I would verify the reagents haven't expired and were properly stored before use.

I would first assess the situation to understand how the breach occurred and what data was compromised. Then, I would inform my supervisor and the data security team to follow the established protocol. After that, I would work on containing the breach to prevent more data loss. I would ensure that we communicate with any stakeholders affected and later review our security measures to avoid this in the future.

I often use tools like IGV for visualizing NGS data because it allows for easy exploration of alignments and variant calls. It's user-friendly and supports large datasets.

In NGS, I monitor metrics like Q30 to assess base quality and ensure accurate sequencing. I also check insert size to verify library preparation and mapping quality to confirm alignment accuracy. Each metric helps in interpreting results properly and identifying issues early.

Open-source software is crucial in NGS as it allows researchers to access and modify analytical tools like BWA and GATK, enhancing collaboration and innovation in the field. By using open-source, labs can significantly reduce costs while benefiting from community support.

I start by defining the biological questions that need the integrated data, then I use tools like Bioconductor for RNA-Seq and SNP data analysis, employing correlation metrics to see relationships. Finally, I interpret the findings based on current literature and visualize them using R.

I believe AI and machine learning will transform NGS by improving data analysis speed and accuracy. For example, these technologies can help in identifying genomic variations more effectively.

Sanger sequencing is a single-read method that processes one DNA fragment at a time, while Next-Generation Sequencing allows for massively parallel sequencing, generating millions of reads simultaneously. NGS is much faster and more cost-effective for large-scale applications.

I would first check the quality of the raw NGS data with FastQC to ensure it meets our standards. Then, I'd align the reads to a reference genome using BWA to prepare for variant calling. After calling variants with GATK, I'd annotate them using databases like dbSNP to understand their biological significance. Finally, I'd connect the findings back to the specific biological questions we are investigating.

A typical NGS data processing pipeline starts with raw data acquisition followed by quality control to ensure high-quality reads. Next, the reads are aligned to a reference genome. After alignment, we identify variants, annotate them, and apply filtering to isolate significant changes. Finally, we visualize the data for interpretation.

To prepare a DNA library for Illumina sequencing, first, I fragment the genomic DNA to around 200-600 base pairs. Then, I ligate specific adapters to the ends of these fragments to allow for sequencing. After that, I perform a cleanup using a bead-based method to remove any leftover reagents. Next, I amplify the library using PCR to ensure I have enough quantity. Finally, I quantify and normalize the library concentration before proceeding to sequencing.

I ensure quality control by first optimizing library preparation protocols and running control samples alongside my experiments. This way, I can verify the accuracy of my sequencing runs.

Next-generation sequencing (NGS) involves sequencing DNA to generate raw data, typically in FASTQ format. The first step is aligning these reads to a reference genome using tools like BWA. After alignment, we use variant callers like GATK to identify SNPs and indels. Filtering is then applied to remove low-quality variants, and finally, we might use ANNOVAR to annotate these variants for biological significance.

One major challenge is the sheer volume of data generated by NGS, often requiring scalable cloud storage solutions. I have managed NGS data using AWS S3 for flexible storage, while also implementing ETL procedures to organize and analyze the data efficiently.

One strategy is to negotiate bulk purchasing agreements for reagents to reduce costs. Additionally, automating library preparation can significantly decrease labor costs while maintaining high quality.